Medjoy Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth 73.30%
- Ebitda 77.01%
- Net Worth -9.66%
- Total Assets 1.18%
About Medjoy Pharmacy
Medjoy Pharmacy Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 August 2017 (Seven years and six months 23 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Naga Kommuri and Ajay Katira serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299TG2017PTC118668
- Company No.
118668
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 2017
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Medjoy Pharmacy?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naga Kommuri  | Director | 02-Aug-2017 | Current |
| Ajay Katira | Director | 02-Aug-2017 | Current |
Financial Performance of Medjoy Pharmacy.
Medjoy Pharmacy Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 73.3% increase in profit. The company's net worth dipped by a decrease of 9.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medjoy Pharmacy?
In 2021, Medjoy Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Merynova Lifesciences International Private LimitedNaga Kommuri is a mutual person
- Merynova Life Sciences India Private Limited
Naga Kommuri is a mutual person
- Myren Life Science India Private Limited
Naga Kommuri is a mutual person
- Myren Biologicals Private Limited
Ajay Katira is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medjoy Pharmacy?
Unlock and access historical data on people associated with Medjoy Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medjoy Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medjoy Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.